|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Additional conditions recognized in this trial | ||||
| Multiple Sclerosis | |||||
| Multiple Sclerosis, Relapsing-Remitting | |||||
| Sclerosis | |||||
| 2 | More general conditions related to this trial | ||||
| Autoimmune Diseases | |||||
| Autoimmune Diseases of the Nervous System | |||||
| Demyelinating Autoimmune Diseases, CNS | |||||
| Demyelinating Diseases | |||||
| Immune System Diseases | |||||
| Nervous System Diseases | |||||
| Pathologic Processes | |||||
| 3 | Interventions listed in this trial | ||||
| Estriol | |||||
| Placebo | |||||
| 4 | Sponsors listed in this trial | ||||
| University of California, Los Angeles | |||||
| Washington University School of Medicine, Saint Louis, MO | |||||
| University of Texas Southwestern Medical Center | |||||
| Ohio State University | |||||
| University of Medicine and Dentistry New Jersey | |||||
| University of Chicago | |||||
| VA Salt Lake City Health Care System | |||||
| National Multiple Sclerosis Society | |||||
| National Institutes of Health (NIH) | |||||
| Pipex Pharmaceuticals, Ann Arnor, MI | |||||